Marianela Perez-Torres

TipoTítuloAutorRespuestasÚltima actualización
Bibliographies[Anesthesia from the patient's point of view]. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesAnaesthesia and the Beckwith-Wiedemann syndrome. Marianela Perez-Torres0Hace 5 años 9 meses
Bibliographies[Preanesthetic study revealing an endobronchial foreign body in an asthmatic patient]. Marianela Perez-Torres0Hace 5 años 9 meses
Bibliographies[Infrequent complication of pulmonary artery catheterization: knot in a Swan-Ganz catheter]. Marianela Perez-Torres0Hace 5 años 9 meses
Bibliographies[Regurgitation through a gastric drainage tube into a Proseal laryngeal mask]. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesVery-high-energy gamma rays from a distant quasar: how transparent is the universe? Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesObservation of pulsed gamma-rays above 25 GeV from the Crab pulsar with MAGIC. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesRadio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Marianela Perez-Torres0Hace 5 años 9 meses
Bibliographies[Loss of consciousness and respiratory depression after a retrobulbar intraorbital block for eye surgery: a case report]. Marianela Perez-Torres0Hace 5 años 9 meses
Bibliographies[Is obesity a risk factor for complications, hospital admissions, and surgical cancellations in ambulatory surgery?] Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesHuman breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesLoss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesHER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesEpidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesShedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Marianela Perez-Torres0Hace 5 años 9 meses
BibliographiesShedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab. Marianela Perez-Torres0Hace 5 años 9 meses

Páginas